- Home
- NXDT vs BWAY Comparison
NXDT vs BWAY Comparison
Compare NXDT & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXDT
- BWAY
- Stock Information
- Founded
- NXDT 2012
- BWAY 2003
- Country
- NXDT United States
- BWAY Israel
- Employees
- NXDT N/A
- BWAY N/A
- Industry
- NXDT Investment Managers
- BWAY Medical/Dental Instruments
- Sector
- NXDT Finance
- BWAY Health Care
- Exchange
- NXDT Nasdaq
- BWAY Nasdaq
- Market Cap
- NXDT 223.1M
- BWAY 216.8M
- IPO Year
- NXDT N/A
- BWAY 2019
- Fundamental
- Price
- NXDT $4.00
- BWAY $12.98
- Analyst Decision
- NXDT
- BWAY Strong Buy
- Analyst Count
- NXDT 0
- BWAY 2
- Target Price
- NXDT N/A
- BWAY $18.00
- AVG Volume (30 Days)
- NXDT 133.6K
- BWAY 45.5K
- Earning Date
- NXDT 01-01-0001
- BWAY 08-13-2025
- Dividend Yield
- NXDT 9.66%
- BWAY N/A
- EPS Growth
- NXDT N/A
- BWAY 515.14
- EPS
- NXDT 0.99
- BWAY 0.11
- Revenue
- NXDT N/A
- BWAY $46,084,000.00
- Revenue This Year
- NXDT N/A
- BWAY $341.83
- Revenue Next Year
- NXDT N/A
- BWAY $23.42
- P/E Ratio
- NXDT $6.41
- BWAY $46.08
- Revenue Growth
- NXDT N/A
- BWAY 26.50
- 52 Week Low
- NXDT $5.89
- BWAY $7.06
- 52 Week High
- NXDT $13.07
- BWAY $13.66
- Technical
- Relative Strength Index (RSI)
- NXDT 37.09
- BWAY 68.08
- Support Level
- NXDT $3.86
- BWAY $11.63
- Resistance Level
- NXDT $4.69
- BWAY $13.10
- Average True Range (ATR)
- NXDT 0.32
- BWAY 0.42
- MACD
- NXDT -0.08
- BWAY 0.12
- Stochastic Oscillator
- NXDT 38.71
- BWAY 93.13
About NXDT NexPoint Diversified Real Estate Trust
NexPoint Diversified Real Estate Trust is a publicly traded REIT focused on opportunistic real estate investments in the United States. Their portfolio includes diverse commercial properties and investments across various real estate sectors and capital structures. The revenue sources of the company include rental income from office and retail properties, interest income from debt investments, dividend income from equity investments, and other ancillary income from tenants. The company operates through its operating partnership and wholly owned subsidiaries.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.